Thyroid hormones (THs) show acrucialactions during the normal development (El-bakry et al.,
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, particularly growth factors such as insulin-growth factor (IGF-1), fibroblast-growth factor (FGF), transforming growth factor-α (TGF-α), and epidermal-growth factor (EGF) . Indeed, integrin αvβ3 is a co-receptor for these growth factors (Saegusa et al., 2009; Ieguchi et al., 2010) . Otherwise, these growth factors may stimulate the release of THs, and generally the development Ahmed, 2016d) . In addition, vascular endothelial growth factor (VEGF), FGF, and basic fibroblast growth factor (bFGF) might prompt THs-induced angiogenesis in the cardiac tissue Zheng et al., 2004) . Also, angiogenesis depends on integrin αvβ3 of both endothelial and vascular smooth muscle cells (Bergh et al., 2005; Candelotti et al., 2015) . Thus, angiogenesis seems to be a good example of the complex interactions between THs and growth factors.
On the other hand, it has been confirmed by the group of Takada and Takada that an integrinbinding defective-FGF1 mutant (R50E) profoundly decreased the ability of the growth factor to induce cell proliferation and migration, even though R50E did provide increase to FGFR1 phosphorylation and downstream 
